Targeting CD123 in AML: A Phase II Trial of Tagraxofusp +/- AZA in Newly Diagnosed sAML After Prior HMA

November 20, 2020 - 8:30am to 9:30am
Series
Hematologic Malignancies Grand Rounds
Speaker
Dr. Steven Green

Hematologic Malignancies Grand Rounds is a weekly teaching conference for hematologic malignancies providers to be able to utilize multidisciplinary methods to keep up with the most current treatment guidelines and changing standards of care for their patients.